1. Home
  2. PEPG vs GCO Comparison

PEPG vs GCO Comparison

Compare PEPG & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$5.47

Market Cap

317.6M

Sector

Health Care

ML Signal

HOLD

Logo Genesco Inc.

GCO

Genesco Inc.

HOLD

Current Price

$34.04

Market Cap

284.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEPG
GCO
Founded
2018
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
317.6M
284.2M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
PEPG
GCO
Price
$5.47
$34.04
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$10.80
$31.33
AVG Volume (30 Days)
684.0K
244.0K
Earning Date
02-23-2026
03-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.00
Revenue
N/A
$2,382,104,000.00
Revenue This Year
N/A
$4.86
Revenue Next Year
N/A
$2.50
P/E Ratio
N/A
$9,503.80
Revenue Growth
N/A
2.76
52 Week Low
$0.88
$16.19
52 Week High
$7.80
$43.81

Technical Indicators

Market Signals
Indicator
PEPG
GCO
Relative Strength Index (RSI) 46.18 58.64
Support Level $5.31 $25.98
Resistance Level $6.20 $38.95
Average True Range (ATR) 0.57 2.29
MACD -0.11 0.63
Stochastic Oscillator 23.03 64.77

Price Performance

Historical Comparison
PEPG
GCO

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

About GCO Genesco Inc.

Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.

Share on Social Networks: